AI assistant
CONMED Corp — Director's Dealing 2017
Jun 2, 2017
31971_dirs_2017-06-02_ee55eb04-131f-493c-a8f9-693677d4d47a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-06-01
Reporting Person: Aronson Martha Goldberg (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-01 | Common Stock | M | 2739 | — | Acquired | 3739 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-01 | Rsus (restricted Stock Units) | $0 | M | 2739 | Disposed | 2026-06-01 | Common Stock (2739) | Direct |
| 2017-06-01 | Rsus (restricted Stock Units) | $0 | A | 2167 | Acquired | 2027-06-01 | Common Stock (2167) | Direct |
| 2017-06-01 | Options To Purchase Common Stock | $51.90 | A | 3669 | Acquired | 2027-06-01 | Common Stock (3669) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.